Cochlear implant upgrades should be free: Labor MP
26 June, 2002 by Tanya HollisHearing impaired Australians should have access to free cochlear implant processor upgrades, according to a Labor MP.
New respiratory medicine exchange program
25 June, 2002 by Melissa TrudingerA million-dollar grant from GlaxoSmithKline has allowed the Institute of Respiratory Medicine to set up a scientist exchange program to allow Australian scientists to travel and work overseas and to bring international scientists to work at the institute.
AIMS solves mystery poison puzzle
25 June, 2002 by Melissa TrudingerAn Australian researcher at the Australian Institute of Marine Science (AIMS) has solved the medical mystery of the death of an East Timorese man from what appeared to be poisoning in late 2000.
R&D Start freeze could shelve cancer project
24 June, 2002 by Tanya HollisA Western Australian research project into the use of carotenoids as a treatment for prostate cancer has been shelved because of the halt to the Federal government's R&D Start program.
Mandatory food labelling, testing laws unworkable: ANZFA
24 June, 2002 by Tanya HollisMandatory, industry-wide food labelling laws would be unworkable and create huge costs for businesses and consumers, according to Australia's peak food authority.
Award kudos for Flinders bioengineers
21 June, 2002 by Claire DobleBiomedical engineering breakthroughs are being achieved at Flinders University. The latest achievement, a bioengineered epidural simulator, has resulted in an Institute of Electrical Engineers (IEE) award for the researcher, postgrad student Olivia Pallotta.
BioFocus lifts stake in AustCancer
21 June, 2002 by Melissa TrudingerAustralian Cancer Technology's joint venture partner BioFocus has strengthened the alliance between the two companies by increasing its holding to more than three per cent.
Tas study shows GM regrowth rare
21 June, 2002 by Tanya HollisThe latest audit of genetically modified crop sites in Tasmania has shown 60 per cent of sites have remained free of re-growth after more than nine months.
Chemeq claims chicken growth success in antimicrobial tests
20 June, 2002 by Melissa TrudingerAn independent study using a polymeric antimicrobial designed by Perth-based biotech Chemeq has demonstrated increased growth rates in chickens at 10 per cent of the dose originally tested in poultry, according to the company.
Autogen discovers gene link between heart disease and diabetes
20 June, 2002 by Tanya HollisGene-discovery company Autogen (ASX: AGT) has discovered a genetic link between diabetes and heart diseases in humans.
BioProspect insecticide set for global field trials
20 June, 2002 by Tanya HollisA natural Western Australian insecticide is to be tested in field trials across Australia, Asia the United States and Europe under an agreement between BioProspect and Nufarm.
Biota names new CEO
20 June, 2002 by Tanya HollisInfection and inflammation drug developer Biota Holdings has named Peter Molloy as its new chief executive, replacing Dr Hugh Niall who is retiring this year.
Agriculture, environment feature in CRC applications
19 June, 2002 by Iain ScottApplications focusing on agriculture, the environment and medical research feature highly in the latest round of applications for funding under the Cooperative Research Centre (CRC) program.
Cultivating hairy roots for herbal medicine
19 June, 2002 by Melissa TrudingerA new technology for growing plant tissues in fermentation tanks may allow large-scale production of the bioactive components of herbal medicines like Echinacea, ginseng and Gynostemma.
Ozgene in US deal to advance its GE rodent program
19 June, 2002 by Tanya HollisAn Australian company will soon be offering genetically altered rodents modified at the single-cell stage to maximise efficiencies.
